News: CM8 Crowd Mobile expands into China with SmartTrans partnership, page-73

First 73 Last

Share
Profile

Follow
Merchant2000

21,678 Posts.

886

02/08/16

09:28

Post #: 18422353
Share

Originally posted by DollarDan ↑

Hello? Any response? Balanced forum here.

Are you a financial advisor?

Hey qqqqq.

You have been very vocal over the the last six months. Always attacking those that were saying that debt restructure was coming, China was coming, Q&A growth was coming that cashflow was strong, that debt was under control.

All these things have happened!

You attacked Marvin, a valuable contributer when his historic, personal, earnings forecast based on available market information was ~20% off over the short term (couple of quarters), in what many still believe was just that, short term.

You quoted our old posts which were written with market info which we had at the time, trying to discredit us.

It seems CM8 are now in a position to operate and focus on their growth strategy comfortably for at least the next 12 months. It seems that track is now stable and that integration and restructuring is beginning to pay off.
They have cash
They have cashflow
They have growing sales.
All the things you disputed.

My point is that you claim to be here to protect peoples capital and you hate to see people lose money. And yet two weeks ago you were claiming CM8 was doomed.

How do you think the sellers that agreed with you and sold out at 14c recently, feel today? How is their capital looking?
Regardless of whether it is short term, they have missed out on a 60% rise.

So why now, do you continue. Self interest?

Expand

''How do you think the sellers that agreed with you and sold out at 14c recently, feel today? How is their capital looking?''

All good Dollar

Interesting reading through your various strong buy and prediction posts in January 2016 at 28.5c -31c lol

DYOR

CM8 Price at posting: 21.5¢ Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 20 more messages in this thread...

First 73 Last

Add UNT (ASX) to my watchlist

(20min delay)
Last 1.6¢		Change -0.001(5.88%)		Mkt cap ! $19.65M

Open	High	Low	Value	Volume
1.7¢	1.7¢	1.6¢	$72.84K	4.540M

Buyers (Bids)

No.	Vol.	Price($)
3	441703	1.6¢

Sellers (Offers)

Price($)	Vol.	No.
1.7¢	59562	1

View Market Depth

No.	Vol.	Price($)
3	441703	0.016
12	2252000	0.015
5	2251225	0.014
6	1105389	0.013
3	1400000	0.012

Price($)	Vol.	No.
0.017	59562	1
0.018	620000	2
0.019	1345000	4
0.020	1138888	5
0.021	1804688	8

Last trade - 16.10pm 07/10/2024 (20 minute delay)

UNT (ASX) Chart

News: CM8 Crowd Mobile expands into China with SmartTrans partnership, page-73

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

News: CM8 Crowd Mobile expands into China with SmartTrans partnership, page-73

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News